ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:1902230;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage;10.0;0.9326813400603323;0.8815816818910864;9.596775554177542;831.2496569477559;6.409777797693995;0.02782117794191935;0.7430373465201421;[BCL2L12, CDKN2D, ING2, SFRP2, BID, TRIM32]
GO:0008584;male gonad development;5.0;1.0;0.7902410118609202;9.628524252492122;50.96471695749156;5.2552850506314295;0.001705743211299806;0.5589965337459591;[PDGFRB, RRM1, SFRP1, SFRP2, CSDE1, RNF38, H3F3A, KIT, SOX8, MEA1, TGFBR1]
GO:0090179;planar cell polarity pathway involved in neural tube closure;10.0;1.0;0.9152410118609203;9.628524252492122;275.5135961891709;7.212124270218933;0.009221192118313007;0.7840693824379941;[SFRP1, SFRP2, DVL3]
GO:0014066;regulation of phosphatidylinositol 3-kinase signaling;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;45.070113835906206;5.202362649177086;0.001508456149618737;0.6169684330707209;[PDGFRB, BECN1, NCF1, ANGPT1, SEMA4D, PTEN, UBE3A, PIK3IP1, CCL5, KIT, CAT, PTPN6, PIP5K1B, TEK, IER3]
GO:0043508;negative regulation of JUN kinase activity;13.0;1.0;0.9625549647676366;9.628524252492122;4937.625749520049;7.138016298065211;0.16525789026176277;0.8275934502023958;[SFRP1, SFRP2, PTPN22]
GO:2000041;negative regulation of planar cell polarity pathway involved in axis elongation;10.0;1.0;0.9152410118609203;9.628524252492122;455.7071039869726;9.083926447120524;0.015252106660676964;0.8797934328124444;[SFRP1, SFRP2]
GO:0045600;positive regulation of fat cell differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.26328322821418;5.71663061713405;0.00382428925936973;0.6154690682008903;[SFRP1, XBP1, SFRP2, ASXL2, SH3PXD2B, STK4, METRNL, STK3]
GO:0046854;phosphatidylinositol phosphorylation;8.0;1.0;0.875;9.628524252492122;218.7418113453505;5.049685808968129;0.007321091570879569;0.6332411671050352;[PDGFRB, SMG1, CD80, IMPAD1, KIT, ZFYVE21, PIK3C3, PIP5K1B, MET, VAV1, PIK3CG, HBEGF]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[ITGB1, CD40, BTG1, PDCD6, ITGB2, CIB1, BRCA1, THBS1, MTDH, AQP1, C3, RRAS, TBXA2R, ABL1, CTSH, MAP3K3, XBP1, ANXA1, JUP, SPHK1, RHOB, RUNX1, PDCL3, SFRP2, SP1, TEK, EPHA1]
GO:0030307;positive regulation of cell growth;6.0;0.6954798709641801;0.6708602480722345;8.712233520617966;80.64681300048527;4.733648510761223;0.0026991762537066665;0.5651993175676412;[MTPN, BMPR2, CSNK2A1, SEMA4D, TNFRSF12A, PARP2, SPHK1, H3F3A, TWF2, DERL2, CIB1, RAB11A, TGFBR1, SFRP1, SFRP2, RUFY3, FGFR1OP, ADNP, TRIM32, EIF4G2, PAFAH1B1, HBEGF]
GO:0045892;negative regulation of transcription, DNA-templated;10.0;0.556709148698489;0.6935955862101648;8.520155788878647;1581.2569993850602;2.683669001811703;0.05292324873051003;0.5524839694169422;[TCERG1, ZNF175, NAB1, GFI1, GMNN, ARID4A, UBP1, ZBTB20, IKZF1, IKZF2, YY1, RPS6KA5, MYC, SAP130, DPF2, TRIM24, WWC3, EP300, SOX8, SOX6, ZNF564, TLE4, ZNF282, ZBTB32, SARS, ZNF12, HCFC2, RUNX2, THAP1, RUNX1, EID1, ILF3, SFRP1, BRMS1, SFRP2, ZNF93, TBL1XR1, PSPC1, CCNE1, HOXB4, TIMELESS, TRIB3, PPID, MAX, FOXG1, MEPCE, SUPT6H, MTDH, BAG3, TPR, HIVEP1, HESX1, SUDS3, BPTF, TFAP2A, DR1, CREBBP, XRCC6, ZNF263, UBE2I, CBX4, XRCC5, WFS1, BCL11A, NONO, CAV1, H3F3A, NFXL1, NFKB1, CNOT7, CDK5, QARS, YEATS2, CNOT1, PKIA, SP3, BCL3, CDK2, ZNF658, NFE2L3, RCOR3, ZNF136, EZH2, CDKN1C, USP36, CIITA, BTG2, YWHAB, TCF25, SUV39H1, CHD8, OTUD7B, BRCA1, LDB2, PTPRK, FLCN, NIPBL, SIN3A, C1QBP, MLX, LRRFIP1, HIF1AN, CIC, JARID2, DACT1, ZNF485, TSC22D4, HELLS, KLF11, HBZ, KLF12, PEG3, RFC1, H2AFY, TSC22D3, SIRT7, ARID1A, SIRT2, ZFP90, DUSP22, NCOR2, NCOR1, RBL1, TFDP2, NFX1, MTF2, DEPDC1, RARA, LCOR, EAPP, MCPH1, HDAC3, ZNF350, HDAC1, GPS2, LRP8, RELA, ARNTL, BCLAF1, RXRA, DNAJB5, RBBP7, MTA2, E2F7, ZNF189, E2F8, TCFL5, IRX1, SPEN, SEMA4D, NFYC, PER2, CENPF, GFI1B, HIST3H2A, NFIA, NFIB, NFIC, TAF7, TRIM33, LIMS1]
GO:0030308;negative regulation of cell growth;6.0;0.6913464685778243;0.6687935468790567;8.673012807464685;80.89021177018715;4.623782033182691;0.0027073225914839173;0.5595807407949613;[SEMA6B, CDKN2D, CDKN1A, G6PD, CDKN2C, BMPR2, BTG1, SEMA4D, EI24, SEMA4B, EAF2, ADIPOR2, PPP2CA, FLCN, SERTAD3, SFRP1, GAL, SFRP2, CDK5, SERTAD2, HYAL2, NPPA, SCGB3A1, RBBP7]
GO:0001701;in utero embryonic development;7.0;1.0;0.8509193652572005;9.628524252492122;22.496195207419138;4.63541007117781;7.529274083310655E-4;0.5879744518658467;[ITGB1, ELL, CHD7, RIC8A, FLCN, CCNB1, FUT8, RXRA, SIN3A, SOX8, MGAT1, ATP7A, SOX6, MBNL1, ENDOG, UBE2B, ANGPT1, TGFBR1, MIB1, ALS2, MAFF, MYH9, CCM2, EIF4E2, APBA3, SEC24C]
GO:0043154;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;12.0;0.8653626801206646;0.8808016526504769;9.556203590912496;734.4861809891323;5.277263957350204;0.024582591483058774;0.7179998367869053;[CDKN2D, CSNK2A1, TNFSF14, PLAUR, TNFRSF10B, TNFRSF10A, SERPINB9, NLRC4, PARK7, UBE2Z, THBS1, AQP1, VIL1, BCL2L12, SFRP2, ADORA2A, BIRC6, RFFL, BIRC3]
GO:0010975;regulation of neuron projection development;8.0;0.5673924682959377;0.6586962341479689;8.404748820870006;84.29486529122617;3.652390236786265;0.0028212732808438556;0.5617834065627654;[BMPR2, GFI1, PTEN, CIB1, PREX1, CFL1, KIF13B, SCARF1, ZNF365, SEMA6B, ACTR2, TNFRSF12A, SERPINF1, PAQR3, OMG, THOC2, NME1, DNM2, GAK, OLFM1, SFRP1, SFRP2, RUFY3, RAPGEF1, ADNP, FKBP4, PAFAH1B1, TWF2, TRAK1, LRP8, RAB21, FXR1, NCKIPSD, ABL1, DVL3, LRIG2, MARK2, TMEM30A, SEMA4D, SEMA4B, SSH3, RAB11A, SSH1, SETX, CCDC88A, CDK5, FES, CAPRIN1, CAMK1, EZH2]
GO:0055007;cardiac muscle cell differentiation;6.0;0.7866048967936545;0.7164227609869718;9.0689084645567;45.916641199513585;6.409777797693995;0.0015367886586535107;0.6509166472493662;[ITGB1, AKAP13, RXRA, RARA, ARID1A, SOX6]
GO:0033138;positive regulation of peptidyl-serine phosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;5.152100814396198;0.026061291479152104;0.6787196871063318;[BCAR3, IL6, BAG4, SFRP2, ANGPT1, CAV1, MTCP1, CAMK1, PARK7, STK4, GFRA2]
GO:1902042;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;10.0;0.9326813400603323;0.8815816818910864;9.589303539338841;425.73912115989816;6.193554689224359;0.014249105244888325;0.731979686697602;[FGA, SFRP2, TRADD, FGG, TMBIM1, TNFRSF10B, RIPK1, TNFRSF10A, BRCA1, PARK7, RFFL]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[CXCL6, OXTR, AHCYL1, DGKD, DGKA, DEFB1, PIK3CG, HEBP1, AKAP13, PREX1, GPR132, GNAT2, RGS1, ADORA3, NPPA, OR56B1, HOMER3, CCR2, PDGFRB, ARHGEF11, ANXA1, SPHK2, SPHK1, RHOC, VAV1, VAV2, RHOB, SFRP1, GAL, SFRP2, ADORA2A, SPNS1, ARHGEF1, DAGLB, GPRC5D, ARHGEF5, XPR1, PTGER4, SUCNR1, RGS19, ROCK2, ADCY4, IQGAP2, CRHR1, RIC8A, C3, ABR, GNG2, TBXA2R, HRH2, CCL5, GRK6, CCL19, ECT2, NTSR1, CCR10, SULT1A3, SLC12A2, CCL20, CAV1, GPR55, TSHR, BAIAP3, GPR180, GNAQ, GNB2, PNOC, NMUR1, CALM3, PTPN6, CALM1, CALM2]
GO:0000902;cell morphogenesis;4.0;0.6260725219892441;0.563036260994622;7.923776160253697;43.26261951924051;4.420487353008457;0.0014479609414792109;0.47606392880653703;[CYFIP2, ITGB1, NCKAP1, ITGB3, LST1, KIF14, STK4, VSIG1, CAPZB, HRH2, ABL1, NCKAP1L, ITGAV, ECT2, SOX6, CAP1, TBCCD1, THOC2, SSH1, P2RX7, BIN3, PARVG, TBC1D20, COL4A4, COL7A1, TEK, EPHA1, MET]
GO:0090263;positive regulation of canonical Wnt signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.417215158824915;236.52854047757646;5.244474134527214;0.007916397387918217;0.6432026511327102;[USP8, SFRP1, SFRP2, JUP, TBL1XR1, CAV1, USP34, UBR5, NFKB1, ARNTL, DACT1]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[SERPINA3, PYGB, GPI, SIGLEC9, FRMPD3, RAB3D, CRISP3, ITGB2, HK3, PSMD7, ACTR1B, FCGR3B, PSMD2, LAMP2, CPNE1, TIMP2, CTSH, ITGAV, CPNE3, CAPN1, GUSB, SNAP29, CAP1, ACTR2, SERPINB1, FCER1G, DBNL, PLAUR, COMMD3, RNASE3, TMEM173, SCAMP1, UNC13D, SERPINB6, VAMP8, ACLY, CAT, TMBIM1, ALDOC, DOCK2, ALDOA, ACPP, SLC27A2, KPNB1, CSTB, PDXK, RAB5C, CLEC12A, UBR4, IQGAP2, PLD1, C3, RAP1B, COMMD9, CYB5R3, ALDH3B1, PSMB1, NCKAP1L, RAB6A, AP1M1, CTSA, XRCC6, TMEM30A, RAB4B, GSN, JUP, XRCC5, HSPA6, SURF4, LILRB3, NFKB1, FABP5, VAPA, IMPDH1, IMPDH2, RAB18, PTX3, MNDA, DEGS1, MAN2B1, PTPN6]
GO:0042662;negative regulation of mesodermal cell fate specification;10.0;0.8436909121759173;0.837086467948879;9.503361109538115;745.9340364622068;8.390779266560578;0.02496574090334154;0.8443458537639685;[SFRP2]
GO:0006897;endocytosis;5.0;0.6324783794010864;0.6064802015614634;8.088079211544972;26.35802846831835;3.582668236575797;8.821794921490709E-4;0.47345883209051776;[ITGB1, SCARB1, DGKD, TFRC, SH3KBP1, NCF2, WIPF2, ITGB3, DENND1A, ITGB2, STON1, CLTA, UBE3A, WASL, FNBP1L, RABEPK, PIK3CG, KIAA1109, ANKFY1, ITGAV, SCARF1, HRAS, CAP1, FCER1G, DBNL, ANXA1, SYK, FNBP1, UNC13D, NME1, DNM2, RUFY1, GAK, ADORA2A, RARA, PIK3C3, RIN3, AMPH, RHOU, DOCK2, MET, CSNK1G2, CSNK1G1, C9orf72, COLEC12, CD163L1, WAS, LRP8, CORO1A, AGER, TM9SF4, HSP90B1, CLN3, HSPH1, CLTCL1, AP2S1, APOL1, AMBP, CAV1, CDC7, MARCH3, MIB1, EHD4, SYNJ1, CDK5, SNX17, CD9, HYOU1, PICALM]
GO:0071560;cellular response to transforming growth factor beta stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;5.788089581116195;0.003262744749111514;0.6191234829421188;[SFRP1, CLEC3B, CAV1, HYAL2, SOX6, TGFBR1, LIMS1]
GO:0043161;proteasome-mediated ubiquitin-dependent protein catabolic process;9.0;0.7586651285174919;0.775573189439035;9.310070521373587;348.3589749790861;4.015022244900292;0.01165926138982685;0.6015690495021188;[CCNF, KIF14, BUB1B, UBE3A, PSMD8, TRIM9, PSMD7, PSMD4, PSMD2, CDC26, SKP2, C18orf25, SEC13, RNF44, FBXO18, RAD23A, KCTD2, KCTD5, SIRT2, DDB1, PSMA1, KCTD10, TBL1XR1, ANAPC5, MAN1B1, DERL3, RNF38, DERL2, PSMB10, PSMA7, ANAPC11, ARNTL, HSP90B1, CCNB1, FZR1, PSMB5, RMND5A, PSMB1, UBQLN1, RFFL, UBE2I, LRRC29, UBE2B, WFS1, EDEM1, SYVN1, FBXL15, ERLIN2, FBXL16, BTBD6, MARCH6, KBTBD4, NSFL1C, ITCH, SPSB1, RNF103, NPLOC4, PSMC1, CDC16, FBXL3, MAD2L1]
GO:0031668;cellular response to extracellular stimulus;4.0;0.5452700253111464;0.5226350126555732;7.377232453885626;45.163559484697416;4.334655917158676;0.0015115836913881548;0.47167450518560927;[BECN1, CDKN1A, SEH1L, BMPR2, MAX, ABCB4, CLEC16A, COMT, AQP3, HSP90B1, WRN, LAMP2, NUDT15, SKP2, FADS1, ATG5, MAP3K5, GABARAPL1, XBP1, EIF2AK3, USF2, EIF2S1, SSH1, P2RX7, SFRP1, TBL2, P2RX4, SFRP2, MARS, PIK3C3, ULK1, ADNP, CPEB4]
GO:0071481;cellular response to X-ray;7.0;1.0;0.8509193652572005;9.628524252492122;60.39874674087868;7.379178354882098;0.0020214916980741903;0.728290889492758;[NIPBL, SFRP1, XRCC6, SFRP2, XRCC5, DNM2]
GO:0050680;negative regulation of epithelial cell proliferation;6.0;0.7307253602413294;0.6884829927108091;8.690254613899192;65.19530579150691;4.989581884898423;0.0021820282128758306;0.5782877622231366;[CDKN1C, CAV1, SERPINF1, ATPIF1, EAF2, PTEN, IFT122, PTPRK, THBS1, WDR13, TGFBR1, SFRP1, CDK6, SFRP2, NFIB]
GO:2000726;negative regulation of cardiac muscle cell differentiation;9.0;0.8436909121759173;0.8180860812682478;9.4949928598676;669.6541776470041;7.292166977892469;0.022412722676212672;0.769162383550154;[G6PD, SOX6]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[ITGB1, ERRFI1, CXCL6, GPI, COPA, GMFB, NCF1, EBI3, CLEC12B, PTEN, IL27, PARK7, METRNL, AGER, CXCL14, CCL5, NPPA, IL12A, FAM3C, CCL19, CAPN1, TIMP1, CMTM7, UBE2I, TNFSF14, CCL20, CD70, BUD31, FLT3LG, NETO2, KLHL24, IL6, GAL, SFRP2, CDK5, IL23A, PNOC, SCGB3A1, CHMP6, KCNK3, HBEGF]
GO:0010667;negative regulation of cardiac muscle cell apoptotic process;10.0;1.0;0.9152410118609203;9.628524252492122;149.61163774803944;6.781341354126479;0.005007366873694588;0.7620391240755716;[SFRP2]
GO:0030336;negative regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.20713857156096;158.04059951544355;4.3090134865453384;0.00528947663847651;0.5712825153487487;[PTGER4, MCTP1, PTEN, MIA3, WASL, PTPRK, THBS1, ABR, FLCN, RRAS, TBXA2R, ADORA3, HYAL2, TP53INP1, ARHGDIB, TIMP1, CLASP1, RNF20, STARD13, IGFBP5, JUP, SERPINF1, IDH2, RHOB, BCR, NISCH, SFRP1, SFRP2, EPHA1]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[PPP1R11, CCNF, UBE3A, BRCA1, UBE2Z, UBE2L3, MED12, TRIM9, NPEPPS, HERC4, TRIM7, HERC1, CDC26, TRIM24, TRIM69, SKP2, C18orf25, ATXN7L3, RNF44, FBXO18, DTX3L, ARRDC1, ZFP91, TRPC4AP, RC3H2, RNF40, PJA2, DDB1, KCTD10, MED20, ANAPC5, BIRC6, THOP1, CBLL1, RNF166, HIST1H2BC, BIRC3, ANAPC13, HIST1H2BO, PCNA, HIST1H2BJ, CDCA3, MGRN1, RNF38, MYCBP2, UBR4, NEDD8, DTX2, KLHL12, NLRC4, ANAPC11, RNF135, VCPIP1, FZR1, RNF213, RMND5A, RAB40C, MED30, RNF138, UBD, HLTF, UBR5, RNF170, RFFL, RNF20, UBE2I, UBE2B, KLHL25, FEM1B, SYVN1, FBXL15, LNPEP, FBXL16, KLHL24, MARCH6, MARCH3, MIB1, CNOT4, ITCH, SPSB1, RNF103, KLHDC8A, UBE2T, RFWD3, ASB8, TSPAN17, KBTBD2, CDC16, FBXL3, TRIM32, ASB3, KBTBD8, TRIM33]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[TFRC, CD80, PDCD6, SIRPG, CCNF, CIB1, IGF1R, AQP1, TIAL1, PPP1CC, MYC, FNTB, SOX8, IL12A, CAPN1, SKP2, MAP3K5, PDGFRB, RPS9, TIPIN, CSNK2A1, IGFBP5, FLT3LG, RUNX2, ERN1, SFRP1, SFRP2, CCNE2, IL23A, CCNE1, EPHA1, CARD11, FOXG1, EBI3, NOLC1, CORO1A, AGER, CCNB1, ABL1, SSR1, NCKAP1L, XBP1, CDC7, CCDC88B, CNOT6, IL6, CDK6, CNOT7, SP1, CDK2, TMEM119, FGFR1OP, CNOT8, MNAT1, CD24, CCNJL, ITGB1, CDKN1A, CD40, WDR48, BMPR2, ITGB3, KIF14, PTEN, LBH, CTSH, ITGAV, TIMP1, ATP7A, HRAS, CCR2, HLA-DPA1, HAVCR2, ANXA1, SYK, SPHK2, ITGA2, SPHK1, FCRL3, TBC1D8, ARNT, PDCD1LG2, IRAK4, TGFBR1, NME1, KIT, RARA, BIRC6, EAPP, HBEGF, CDC123, HDAC1, DERL2, CRIP2, THBS1, RELA, FZR1, HLA-DMB, CCL5, MFN2, CCL19, IL12RB1, TBX1, MAP3K3, TSHR, PDCL3, CD4, GPAM, HLA-DPB1, KRAS, PTPN6, FAM98A, TEK]
GO:0002063;chondrocyte development;4.0;0.8933024483968273;0.6966512241984136;9.474373572664863;32.15320660831846;6.943860283624253;0.001076138889173156;0.6051093378270707;[BMPR2, SFRP2, IMPAD1, EIF2AK3, RUNX2]
GO:0006661;phosphatidylinositol biosynthetic process;8.0;0.7508913569872202;0.7504456784936101;9.237657943805111;661.808482261977;4.917261223318797;0.022150134312343243;0.6264689676365554;[ARF3, VAC14, PIGU, PLEKHA2, PTEN, PIK3CG, MTMR6, MTM1, RUFY1, DPM3, SYNJ1, PIGA, PIK3C3, PIP5K1B, SBF1]
GO:0045669;positive regulation of osteoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;169.86351353303945;5.734022359845919;0.005685178930713632;0.6163584827319739;[IL6, BMPR2, SFRP2, TMEM119, FAM20C, RUNX2]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[CRTC2, ZNF175, CCNK, MAML1, CCNH, GFI1, ZNF292, ARID4A, RORA, YEATS4, UBE3A, IKZF1, PARK7, IKZF2, ELK1, YY1, RPS6KA4, RPS6KA5, MYC, DPF2, EP300, SOX8, SOX6, IER5, ZNF564, IER2, CDK5RAP3, DDX17, MEF2B, FLT3LG, MED6, RUNX2, PIAS2, RUNX1, ARMCX3, SFRP2, IL23A, TBL1XR1, RFX4, HOXB4, PAXIP1, MAX, RLF, SUPT6H, BCL2L12, HSPH1, RAD21, HLTF, SCAP, NLRP3, HOXC4, ZBED1, RIPK1, CYTL1, TFAP2A, ZBTB17, ZNF143, DR1, CREBBP, XBP1, XRCC6, JUP, PBX3, EAF2, ERLIN2, FLI1, NFKB1, SETX, CDK9, NFKBIA, IL6, STAG1, TFCP2, COPS5, CNOT7, SP1, SP3, MAFF, BCL3, MNAT1, NFE2L1, ARF4, CIITA, CD40, SETD3, BMPR2, ONECUT2, ELL, CHD8, CHD7, DDX41, HOXC13, BRCA1, LDB2, AATF, PKD2, MED12, FLCN, NIPBL, SIN3A, HYAL2, MLX, HRAS, TEAD2, ZNF485, KLF13, RBM15, PPP1R12A, PEG3, NCOA6, MKL1, ARNT, SENP2, SAFB, TMEM173, PPRC1, SIRT2, GNL3, CREB3, GAL, TFDP1, RBL1, TFDP2, ELF4, IRF4, MTF2, TFEC, RARA, EAPP, MET, HDAC3, ZNF350, HDAC1, WBP2, CEBPG, GPS2, RELA, ARNTL, RXRA, PLAGL2, MTA2, E2F7, E2F8, TBX1, ZNF462, NFYC, ATAD2, ARID3B, GRHL1, USF2, KLF6, NFIA, TNIP1, NFIB, TNIP2, TTC5, NFIC, PSMC1, ASXL2, TAF7, CAMK1, TAF4, MIXL1]
GO:1904956;regulation of midbrain dopaminergic neuron differentiation;9.0;0.8259837884571596;0.8092325194088689;9.485423408851448;65.91985791570636;8.16763571524637;0.002206278320418209;0.8139338954918922;[SFRP1, SFRP2]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[TCERG1, ZNF175, GFI1, ZBTB20, IKZF2, YY1, MYC, SAP130, WWC3, EP300, SOX8, SOX6, ZNF564, TLE4, ZBTB32, SARS, HCFC2, THAP1, RUNX1, EID1, BRMS1, TBL1XR1, CCNE1, HOXB4, TIMELESS, TRIB3, PPID, MAX, FOXG1, MEPCE, MTDH, BAG3, TPR, HIVEP1, HESX1, SUDS3, BPTF, TFAP2A, DR1, CREBBP, ZNF263, UBE2I, CBX4, WFS1, BCL11A, CAV1, NFXL1, NFKB1, CNOT7, YEATS2, CNOT1, PKIA, SP3, CDK2, NFE2L3, RCOR3, ZNF136, EZH2, CIITA, BTG2, TCF25, SUV39H1, CHD8, OTUD7B, LDB2, FLCN, NIPBL, SIN3A, C1QBP, MLX, LRRFIP1, HIF1AN, CIC, JARID2, DACT1, KLF11, HBZ, KLF12, PEG3, RFC1, H2AFY, TSC22D3, SIRT7, ARID1A, SIRT2, ZFP90, DUSP22, NCOR2, NCOR1, RBL1, NFX1, MTF2, RARA, LCOR, EAPP, MCPH1, HDAC3, ZNF350, HDAC1, GPS2, LRP8, RELA, RXRA, DNAJB5, RBBP7, MTA2, E2F7, ZNF189, E2F8, TCFL5, IRX1, SPEN, SEMA4D, PER2, GFI1B, NFIA, NFIB, NFIC, TAF7, TRIM33]
GO:0010719;negative regulation of epithelial to mesenchymal transition;6.0;0.8259837884571596;0.7361122068187242;9.434368238051164;171.1659509920613;6.481236761676141;0.005728770340349481;0.6545710619905948;[PPP2CA, SFRP1, SFRP2, PTEN]
GO:0001569;branching involved in blood vessel morphogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;53.5045405888233;6.375876246018314;0.0017907488225476112;0.6769819729871445;[RBM15, SFRP2, STK4]
GO:0060070;canonical Wnt signaling pathway;8.0;0.6729672293956388;0.7114836146978194;8.391761625343195;31.415129658942366;5.233778845410465;0.0010514361179036673;0.6426556935498979;[MED12, SFRP1, SFRP2, UBE2B, RYK, MYC, CHD8, PTEN, DVL3, SDC1]
GO:0033630;positive regulation of cell adhesion mediated by integrin;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;34.61675044652454;6.943860283624253;0.0011585914843924019;0.6453503496879909;[SFRP2, SYK, CCL5, CIB1, NCKAP1L, PTPN6]
GO:0010950;positive regulation of endopeptidase activity;10.0;0.7436939687323844;0.7870879962271125;9.418803721510052;499.32903666023907;4.7018998124466425;0.01671209349006058;0.6556963869301439;[CYFIP2, DIABLO, ROCK2, PDCD6, TRADD, NLRC4, BBC3, PERP, MYC, CASP3, ARL6IP5, NLRP2, NLRP3, CTSH, MBP, RIPK1, BID, MAP3K5, PRELID1, GSN, EIF2AK3, TNFRSF10B, TNFRSF10A, HSPE1, NLRP12, SFRP2, PSME2, PICALM]
GO:0050732;negative regulation of peptidyl-tyrosine phosphorylation;10.0;0.7980440201809971;0.8142630219514189;9.446202695698167;781.0212663083519;5.926926025970411;0.02614007890983527;0.7183442844592942;[PPP2CA, ERRFI1, SFRP1, SH3BP5L, SFRP2, SEMA4D, CAV1, HYAL2, FGFR1OP, PTPN6, CHMP6]
GO:0016458;gene silencing;7.0;0.6835726970475526;0.6927057137809769;8.659123695304018;69.21166146355857;4.8942717050940985;0.002316452022733967;0.6012126478626229;[DDX17, HELLS, H2AFY, HDAC1, SUV39H1, H3F3A, CNOT10, HELZ, SUPT6H, SND1, SIRT2, CNOT6, HIST3H2A, CNOT7, CNOT1, CNOT3, CNOT8, SOX6, TNRC6A]
GO:0048708;astrocyte differentiation;5.0;0.8933024483968273;0.736892236059334;9.34084218004034;23.145667324477426;7.004484905440688;7.746646556020492E-4;0.6484506956670166;[ABL1, SOX6]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[TCERG1, ZNF175, CCNK, CCNH, GFI1, ZNF292, IKZF1, GPATCH3, IKZF2, ELK1, UBE2L3, MYC, SAP130, ZXDC, DPF2, TRIM24, CPNE1, SOX8, SOX6, IER5, ATXN7L3, IER2, DDX17, ZNF18, SAP30BP, MEF2B, CSNK2A1, ZNF282, RFX1, ZNF12, SND1, THAP1, RUNX1, EID1, EWSR1, RFX4, HOXB4, TRIB3, BCORL1, ASF1B, SF1, ZNF276, ZNF395, ZNF274, ZNF394, PAXIP1, FOXG1, MYCBP2, ZNF20, CDCA7, ZNF23, RPAP1, ZNF25, COMMD9, RAD21, HLTF, HIVEP1, HESX1, HOXC4, ZBED1, HIVEP2, ZNF264, ZNF143, XBP1, XRCC6, ZNF263, SETDB1, ZNF260, XRCC5, BCL11A, INTS3, PBX3, EAF2, ZNF35, FLI1, SOX30, STAG1, ZNF30, INTS4, INTS7, INTS6, RCOR3, ZNF136, INTS8, EZH2, PHF3, SETD5, BTG2, SETD3, ELL, ZNF250, TCF25, SUV39H1, INTS10, ATF7IP2, HOXC13, BRCA1, WASL, WDR43, NIPBL, CHAF1B, ING2, ZMYM2, SCML1, C1QBP, HYAL2, MLX, CIC, JARID2, ZNF485, BRD3, TSC22D4, HELLS, COMMD3, BAZ1A, COMMD1, SIRT7, PPRC1, ZFX, MED29, SIRT2, MED28, NCOR2, NCOR1, NFX1, TFEC, MED20, DEPDC1, VGLL4, ZNF234, ZNF350, HEATR1, GPS2, ZNF2, ZNF69, RELA, ARNTL, SERTAD3, BCLAF1, SERTAD2, TCEAL3, PLAGL2, GPBP1L1, DEDD, ZNF101, ZNF462, ZNF581, NFYC, ATAD2, GRHL1, GTF2H4, PER2, GFI1B, NFIA, NFIB, NFIC, MARS, ZNF213, ZNF696, MIXL1, ZNF212, ZNF331, CRTC2, NAB1, ARID4A, UBP1, ZBTB20, YEATS4, YY1, EP300, ZNF326, ZNF688, ZNF564, GTF2I, TLE4, ZNF441, ZNF680, ZBTB32, SARS, PIAS2, ERN1, ILF3, BRMS1, ZNF93, TBL1XR1, PSPC1, TIMELESS, ADNP, ZNF550, MAX, RLF, SUPT6H, GTF2E2, ZNF549, ZNF548, NLRP3, SUDS3, ZNF544, BPTF, TRAPPC2, TFAP2A, ZBTB17, DR1, CBX4, NONO, NFXL1, CNOT10, NFKB1, CDK9, CNOT6, IRAK1BP1, TFCP2, COPS5, CNOT7, CNOT1, SP1, SP4, SP3, MAFF, BCL3, CNOT3, ZFP64, ZNF658, NFE2L3, ZNF777, CNOT8, TMEM18, MNAT1, ZNF654, ZNF532, ZNF410, NFE2L1, ZSCAN2, PHF19, NFKBIB, PHTF2, CIITA, BMPR2, ONECUT2, CHD9, CHD8, CHD7, CHD1, AFF4, LBH, SIN3A, ZNF407, NUP62, ZNF768, ZNF525, ZNF524, ZNF766, LRRFIP1, HIF1AN, KLF11, KLF12, TBP, KLF13, RFC1, BUD31, MKL1, ARNT, SAFB, ARID1A, ZFP90, CREB3, TFDP1, RBL1, ZNF519, TFDP2, ELF4, IRF4, ZNF516, LCOR, ZNF511, ZNF630, ITGB3BP, GTF3C1, SMARCD2, HDAC3, HDAC1, WBP2, CEBPG, TFPT, POLR2B, RBBP5, TP53INP2, FAM120B, TP53INP1, TAF1A, POLR2E, SAP18, POLR2G, ASCC3, RBBP7, E2F7, ZNF189, E2F8, TCFL5, TBX1, POLR2J3, SPEN, CHURC1, EYA2, ARID3B, DEK, USF2, PNRC1, MAPK13, KLF6, POLR3B, POLR3C, TNIP2, POLR3E, ASXL2, TAF7, MNDA, TAF5, TAF4, TRIM33]
GO:0061185;negative regulation of dermatome development;7.0;1.0;0.8509193652572005;9.628524252492122;121.41107568444949;9.777073627680469;0.004063519440284355;0.8509193652572005;[SFRP2]
GO:0090244;Wnt signaling pathway involved in somitogenesis;8.0;1.0;0.875;9.628524252492122;31.415129658942366;8.390779266560578;0.0010514361179036673;0.8041048419030481;[SFRP1, SFRP2]
GO:0048821;erythrocyte development;5.0;0.8933024483968273;0.736892236059334;9.377209824211215;33.53950096943652;6.832634648514029;0.0011225369138558525;0.639662265535933;[ARID4A, NCKAP1L, BPGM, SOX6]
GO:0006357;regulation of transcription by RNA polymerase II;10.0;0.43649654099988644;0.6334892823608635;7.109131426632953;248.56913769389934;1.8913682364374496;0.008319385340914571;0.5119656714299493;[TCERG1, ZNF175, CCNK, MAML1, CCNH, GFI1, ZNF292, IKZF1, IKZF2, ELK1, TIAL1, RPS6KA4, RPS6KA5, MYC, SAP130, ZXDC, DPF2, SOX8, SOX6, IER5, ATXN7L3, IER2, CDK5RAP3, DDX17, ZNF18, MEF2B, ZNF282, FLT3LG, RFX1, ZNF12, HCFC2, MED6, RUNX2, RC3H2, THAP1, RUNX1, EID1, THAP6, SFRP1, TWSG1, SFRP2, IL23A, RFX4, BOLA3, HOXB4, TRIB3, ANKRA2, ZNF276, ZNF395, ZNF274, ZNF394, PAXIP1, FOXG1, MEPCE, ZNF20, ZNF23, ZNF25, MTDH, HSPH1, RAD21, HLTF, HIVEP1, HESX1, SCAP, HOXC4, ZBED1, HIVEP2, ZNF264, ZNF143, CREBBP, XBP1, XRCC6, ZNF263, JUP, ZNF260, BCL11A, PBX3, EAF2, ERLIN2, ZNF35, FLI1, SOX30, SETX, STAG1, PKIA, ZNF30, RCOR3, ZNF136, PAM, EZH2, ARF4, AHCTF1, BTG2, CDKN1A, CD40, SETD3, ELL, ZNF250, TCF25, SUV39H1, OTUD7B, HOXC13, ZNF45, BRCA1, AATF, MED12, NIPBL, ZMYM2, C1QBP, HYAL2, MLX, CIC, JARID2, HRAS, TEAD2, HAVCR2, ZNF485, BRD3, TSC22D4, HBZ, NCOA6, TSC22D3, TSC22D2, SIRT7, TMEM173, PPRC1, ZFX, SIRT2, GNL3, TOX4, NCOR2, GAL, NCOR1, NFX1, MTF2, TFEC, MED20, KIT, RARA, ZNF234, ZNF350, GPS2, NEDD8, ZNF2, TRAK1, ZNF69, RELA, ARNTL, RXRA, TCEAL3, UBN1, PLAGL2, ZNF101, ZNF462, EGLN2, ZNF581, NFYC, ATAD2, GRHL1, GTF2H4, PER2, GFI1B, NFIA, NFIB, TTC5, NFIC, PSMC1, CAMK1, ZNF213, ZNF696, MIXL1, ZNF212, ZNF331, CRTC2, ARID4A, UBP1, ZBTB20, RORA, YEATS4, UBE3A, PARK7, YY1, WWC3, EP300, ZNF564, GTF2I, TLE4, ZNF441, ZNF680, SSU72, ZBTB32, SARS, LEMD3, PIAS2, ARMCX3, BRMS1, ZNF93, TBL1XR1, PSPC1, CCNE1, TIMELESS, ADNP, PPID, ZNF550, MAX, RLF, SUPT6H, BCL2L12, MED30, BAG3, TPR, ZNF549, ZNF548, ABL1, NLRP3, RIPK1, CYTL1, SUDS3, ZNF544, BPTF, TFAP2A, ZBTB17, DR1, UBE2I, CBX4, WFS1, NONO, CAV1, NFXL1, NFKB1, CDK9, NFKBIA, IL6, TFCP2, COPS5, CNOT7, YEATS2, CNOT1, SP1, SP4, SP3, MAFF, BCL3, CDK2, ZFP64, ZNF658, NFE2L3, ZNF777, MNAT1, ZNF654, ZNF532, ZNF410, NFE2L1, ZSCAN2, CIITA, BMPR2, ONECUT2, CHD8, CHD7, DDX41, LDB2, PKD2, CHD1, FLCN, SIN3A, ZNF407, GATAD1, ZNF768, ZNF525, ZNF524, ZNF766, LRRFIP1, HIF1AN, DACT1, KLF11, KLF12, TBP, KLF13, RBM15, PPP1R12A, PEG3, RFC1, H2AFY, BUD31, MKL1, ZFP91, ARNT, SENP2, SAFB, ARID1A, ZFP90, DUSP22, CREB3, TFDP1, RBL1, ZNF519, TFDP2, SETBP1, ELF4, IRF4, ZNF516, LCOR, ZNF511, EAPP, MET, MCPH1, SMARCD2, HDAC3, HDAC1, WBP2, CEBPG, LRP8, DNAJB5, SAP18, ZNF622, RBBP7, MTA2, E2F7, ZNF189, E2F8, TCFL5, IRX1, TBX1, SPEN, SEMA4D, FBXL15, ARID3B, DEK, USF2, KLF6, TNIP1, TNIP2, ASXL2, TAF7, TAF4, TRIM33]
GO:0030514;negative regulation of BMP signaling pathway;12.0;0.8259837884571596;0.8611122068187244;9.4949928598676;599.3292772798114;5.905872616772578;0.02005901154922404;0.7501469128630576;[SFRP1, TWSG1, SFRP2, ABL1, LEMD3, TRIM33]
GO:0090090;negative regulation of canonical Wnt signaling pathway;8.0;0.7866048967936545;0.7683024483968273;9.283683766200392;236.99226377157444;4.932886541221878;0.00793191778924446;0.6272680471207706;[TLE4, HDAC1, CAV1, CHD8, KLHL12, STK4, STK3, CYLD, SFRP1, SFRP2, RAPGEF1, DVL3, EMD, DACT1]
GO:0007517;muscle organ development;4.0;0.7763722522362496;0.6381861261181248;8.753055515138222;27.682183388997124;5.085725745451326;9.264977656821302E-4;0.5100842511328143;[TBX1, FXR1, CENPF, XBP1, MEF2B, SOX6, VAMP5, EMD, HBEGF]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[NCF1, NCF2, CRISP3, DEFB1, IL27, LYST, PIK3CG, PPP6C, C1QBP, HAVCR2, MAP3K5, FGA, MAP4K2, FCER1G, ANXA1, DTX3L, SYK, WRNIP1, RNASE3, IRAK4, TMEM173, SIRT2, IL23A, ELF4, PSPC1, TRIM14, TLR7, HIST1H2BC, ANKRD17, COLEC12, HIST1H2BJ, CFH, CEBPG, NLRC4, ZC3HAV1, LILRA2, CORO1A, AGER, RELA, C2, C3, RNF135, CLEC7A, PRDX1, NLRP2, ABL1, SLAMF7, NLRP3, CSK, APOL1, XRCC6, PPP1R14B, APOBEC3F, APOBEC3H, XRCC5, NONO, MX2, NFKB1, ANKHD1, CYLD, ITCH, POLR3B, POLR3C, FES, TREML4, POLR3E, PTX3, PTPN6, SERINC3, TRIM32, CD244, APOBEC3A, C1QC]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[PDCD6, PARK7, UBE2Z, PREX1, RASSF2, RPS6KA2, MYC, ARL6IP5, IL12A, MAP3K5, PDGFRB, ENDOG, FBXO18, RPS7, SFRP1, BRMS1, SFRP2, PPIF, PPID, DIABLO, STK4, STK3, ABR, UBD, TP53BP2, NLRP2, ABL1, NLRP3, RIPK1, SUDS3, ECT2, NTSR1, TFAP2A, PRNP, PRELID1, CAV1, EIF2AK3, TNFRSF10B, TNFRSF10A, EIF2S1, CYLD, IL6, CDK5, SERINC3, HRK, ITGB1, CD40, BTG1, YWHAB, TRADD, PTEN, BBC3, FLCN, AKAP13, C1QBP, CASP3, HYAL2, CASP2, CTSH, CTLA4, RBM5, ARHGEF11, KLF11, DFFA, C3orf38, ANXA1, TNFRSF12A, RIPK3, ATPIF1, PLAUR, YWHAZ, SIRT2, VAV1, TGFBR1, VAV2, RHOB, DNM2, GAL, TFDP1, TFDP2, ADORA2A, PTRH2, ARHGEF1, GAPDH, ARHGEF5, ITGB3BP, NLRC4, THBS1, BCLAF1, CCL5, TP53INP1, SAP18, PLAGL2, MFN2, ZNF622, BID, GSN, G0S2, HSPE1, P2RX7, NLRP12, FAP, MNDA, PDCD1, LTBR]
GO:2000741;positive regulation of mesenchymal stem cell differentiation;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;146.28124190880965;8.390779266560578;0.00489590152211723;0.7800242071602487;[SOX6]
GO:0030199;collagen fibril organization;5.0;1.0;0.7902410118609202;9.628524252492122;53.964823970696955;5.9928839937622085;0.0018061540931107725;0.5967173779995258;[COL1A2, SFRP2, COL5A1, ATP7A, TGFBR1]
GO:0032332;positive regulation of chondrocyte differentiation;7.0;0.8933024483968273;0.7975705894556142;9.567899630675686;229.711107350086;6.832634648514029;0.007688224036432589;0.7003406189322132;[SOX6, RUNX2, RELA]
